Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KPTI

Karyopharm

$11.52

-0.4 (-3.36%)

08:15
11/09/18
11/09
08:15
11/09/18
08:15
Upgrade
Karyopharm rating change at Wedbush »

Karyopharm upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 06

    Apr

KPTI

Karyopharm

$11.52

-0.4 (-3.36%)

06:36
11/09/18
11/09
06:36
11/09/18
06:36
Upgrade
Karyopharm rating change at Wedbush »

Karyopharm upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 06

    Apr

KPTI

Karyopharm

$11.92

0.69 (6.14%)

07:06
11/08/18
11/08
07:06
11/08/18
07:06
Earnings
Karyopharm reports Q3 EPS (79c), consensus (89c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 01

    Dec

  • 06

    Apr

KPTI

Karyopharm

$11.23

0.08 (0.72%)

08:10
11/07/18
11/07
08:10
11/07/18
08:10
Hot Stocks
Karyopharm's Selinexor receives FDA fast track designation »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 01

    Dec

  • 06

    Apr

KPTI

Karyopharm

$10.75

0.21 (1.99%)

10:20
11/01/18
11/01
10:20
11/01/18
10:20
Hot Stocks
Karyopharm to present results of clinical studies investigating selinexor »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 06

    Apr

KPTI

Karyopharm

$11.05

0.3 (2.79%)

07:08
10/26/18
10/26
07:08
10/26/18
07:08
Hot Stocks
Karyopharm CFO Mike Falvey to depart »

Karyopharm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Apr

Over a month ago
KPTI

Karyopharm

$15.00

0.19 (1.28%)

17:45
10/05/18
10/05
17:45
10/05/18
17:45
Hot Stocks
FDA accepts Karyopharm NDA for Selinexor with priority review »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KPTI

Karyopharm

$18.98

0.49 (2.65%)

16:09
09/20/18
09/20
16:09
09/20/18
16:09
Hot Stocks
Karyopharm announces oral presentation relating to selinexor »

Karyopharm Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ABBV

AbbVie

$95.69

-0.67 (-0.70%)

, AGIO

Agios Pharmaceuticals

$73.42

-1.085 (-1.46%)

04:55
09/15/18
09/15
04:55
09/15/18
04:55
Conference/Events
Society of Hematologic Oncology to hold annual meeting »

SOHO 2018: 6th Annual…

ABBV

AbbVie

$95.69

-0.67 (-0.70%)

AGIO

Agios Pharmaceuticals

$73.42

-1.085 (-1.46%)

ALXN

Alexion

$118.19

-0.84 (-0.71%)

AMGN

Amgen

$200.54

-2.4 (-1.18%)

AZN

AstraZeneca

$37.45

-0.17 (-0.45%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$60.69

-0.11 (-0.18%)

CELG

Celgene

$87.18

-1.57 (-1.77%)

DNA

Bought by RHHBY

$0.00

(0.00%)

EPZM

Epizyme

$10.15

-0.05 (-0.49%)

GILD

Gilead

$73.38

-0.73 (-0.99%)

INCY

Incyte

$68.10

0.63 (0.93%)

JAZZ

Jazz Pharmaceuticals

$163.05

-2.17 (-1.31%)

KPTI

Karyopharm

$18.71

-0.15 (-0.80%)

LOXO

Loxo Oncology

$163.97

-1.38 (-0.83%)

MRK

Merck

$69.98

-0.4 (-0.57%)

NVS

Novartis

$85.26

-0.05 (-0.06%)

PFE

Pfizer

$42.97

0.11 (0.26%)

SGEN

Seattle Genetics

$78.22

1.02 (1.32%)

SHPG

Shire

$177.31

4.93 (2.86%)

SNSS

Sunesis

$1.86

-0.08 (-4.12%)

TEVA

Teva

$22.84

0.63 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 16

    Sep

  • 18

    Sep

  • 18

    Sep

  • 20

    Sep

  • 20

    Sep

  • 23

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 20

    Dec

  • 21

    Dec

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

ABBV

AbbVie

$96.36

3.11 (3.34%)

, AGIO

Agios Pharmaceuticals

$74.50

0.33 (0.44%)

04:55
09/14/18
09/14
04:55
09/14/18
04:55
Conference/Events
Society of Hematologic Oncology to hold annual meeting »

SOHO 2018: 6th Annual…

ABBV

AbbVie

$96.36

3.11 (3.34%)

AGIO

Agios Pharmaceuticals

$74.50

0.33 (0.44%)

ALXN

Alexion

$119.03

0.8 (0.68%)

AMGN

Amgen

$202.94

3.44 (1.72%)

AZN

AstraZeneca

$37.62

-0.265 (-0.70%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$60.80

0.48 (0.80%)

CELG

Celgene

$88.75

1.95 (2.25%)

DNA

Bought by RHHBY

$0.00

(0.00%)

EPZM

Epizyme

$10.20

0.45 (4.62%)

GILD

Gilead

$74.11

0.7 (0.95%)

INCY

Incyte

$67.47

0.93 (1.40%)

JAZZ

Jazz Pharmaceuticals

$165.22

-0.64 (-0.39%)

KPTI

Karyopharm

$18.86

0.25 (1.34%)

LOXO

Loxo Oncology

$165.35

0.44 (0.27%)

MRK

Merck

$70.86

1.01 (1.45%)

NVS

Novartis

$85.31

0.88 (1.04%)

PFE

Pfizer

$42.86

0.46 (1.08%)

SGEN

Seattle Genetics

$77.20

0.19 (0.25%)

SHPG

Shire

$172.38

-0.39 (-0.23%)

SNSS

Sunesis

$1.94

-0.09 (-4.43%)

TEVA

Teva

$22.21

0.01 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

  • 15

    Sep

  • 16

    Sep

  • 18

    Sep

  • 18

    Sep

  • 20

    Sep

  • 20

    Sep

  • 23

    Sep

  • 26

    Sep

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 20

    Dec

  • 21

    Dec

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.